Regulation of Exocytosis in the Post-Ischemic Myocardium
缺血后心肌胞吐作用的调节
基本信息
- 批准号:7160736
- 负责人:
- 金额:$ 40.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Ischemia and reperfusion trigger the rapid release of endothelial granules containing mediators of vascular
inflammation and thrombosis, including P-selectin, interleukin-8, and von Willebrand factor. P-selectin is
translocated from the interior of the endothelial cell to the exterior surface, where it mediates leukocyte
adherence to the endothelial wall. Interleukin-8 is released into the blood, where it can activate leukocytes,
increasing the interactions between leukocytes and endothelial cells. Endothelial exocytosis is thus an early step
in leukocyte trafficking into the ischemic myocardium.
The over-all goal of this project is to characterize the mechanisms by which exocytosis of endothelial granules
leads to injury in the post-ischemic myocardium. We have previously identified components of the exocytic
machinery of endothelial cells. We subsequently discovered that nitric oxide inhibits vascular inflammation by
inhibiting specific proteins that mediate exocytosis. We then developed a novel polypeptide that interferes with
the exocytic machinery, inhibits exocytosis, and decreases vascular inflammation. We now propose to extend
these studies to explore the mechanisms of exocytosis in post-ischemic myocardium.
We first plan to study how hypoxia activates exocytosis. We will focus on the role of signaling
intermediates such as calcineurin which regulate exocytosis by post-translational modifications of the exocytic
machinery. We will then characterize the role of one particular component of the exocytic machinery in postischemic
inflammation. We will finally define a novel mechanism which regulates a major stress response
pathway in hypoxic endothelial cells. Each of these aims includes a wide range of studies, from recombinant
proteins to transduced cells to animal experiments. These studies will increase our understanding of the
molecular mechanisms regulating endothelial exocytosis, and will lead to novel therapies that inhibit
inflammation and injury to the post-ischemic myocardium.
缺血再灌注触发含有血管介质的内皮颗粒的快速释放
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES J LOWENSTEIN其他文献
CHARLES J LOWENSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES J LOWENSTEIN', 18)}}的其他基金
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology
口服避孕药诱发的 VTE 模型系统:将基因组学、转录组学和蛋白质组学发现与功能生物学相结合
- 批准号:
10418628 - 财政年份:2020
- 资助金额:
$ 40.84万 - 项目类别:
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology
口服避孕药诱发的 VTE 模型系统:将基因组学、转录组学和蛋白质组学发现与功能生物学相结合
- 批准号:
10164668 - 财政年份:2020
- 资助金额:
$ 40.84万 - 项目类别:
Population genomic variation, functional biology, and the risk of venous thrombosis
群体基因组变异、功能生物学和静脉血栓形成的风险
- 批准号:
9750789 - 财政年份:2017
- 资助金额:
$ 40.84万 - 项目类别:
VAMP8 regulates endothelial exocytosis and microvascular obstruction
VAMP8 调节内皮胞吐作用和微血管阻塞
- 批准号:
8903561 - 财政年份:2014
- 资助金额:
$ 40.84万 - 项目类别:
相似国自然基金
乳酸通过Ca2+/Calcineurin/TFEB信号轴在氧化应激诱导视网膜退行性变中的作用机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:地区科学基金项目
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在B1AR自身抗体诱导心房重构中的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:青年科学基金项目
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在β1AR自身抗体诱导心房重构中的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:青年科学基金项目
STING-Ca2+-Calcineurin 负反馈环在机体维
持抗病毒天然免疫稳态中的机制研究
- 批准号:Q24H100001
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
神经介素U通过NMUR1/calcineurin/NAFT 通路介导ARDS神经免疫环路调控的研究
- 批准号:
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
神经分泌NMU通过NMUR1/calcineurin/NFAT通路调控ILC2介导的ARDS免疫炎症的效应及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
Rcan2抑制Calcineurin活性决定尾鳍极性再生的机制研究
- 批准号:32170853
- 批准年份:2021
- 资助金额:57 万元
- 项目类别:面上项目
Calcineurin/CRTC2轴介导的CD206+MerTK+巨噬细胞-肝细胞互作重塑移植肝糖稳态研究
- 批准号:82171757
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
基于calpain1-calcineurin-TFEB通路介导的神经元ALP障碍研究西洋参拟人参皂苷F11抗脑缺血作用机制
- 批准号:
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
甲基转移酶 SETD2 调控 Calcineurin 信号抑制线粒体分裂在胶质母细胞瘤细胞增殖与侵袭中的作用及机制
- 批准号:
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic Activity
Polo 样激酶 2 依赖性 α-突触核蛋白丝氨酸 129 磷酸化:突触活动期间的生理作用
- 批准号:
10522495 - 财政年份:2022
- 资助金额:
$ 40.84万 - 项目类别:
Calcineurin activation and scaffolding in A Beta-induced synaptic dysfunction
A Beta 诱导的突触功能障碍中钙调神经磷酸酶的激活和支架
- 批准号:
10668499 - 财政年份:2021
- 资助金额:
$ 40.84万 - 项目类别:
Calcineurin activation and scaffolding in A Beta-induced synaptic dysfunction
A Beta 诱导的突触功能障碍中钙调神经磷酸酶的激活和支架
- 批准号:
10312481 - 财政年份:2021
- 资助金额:
$ 40.84万 - 项目类别:
Calcineurin activation and scaffolding in A Beta-induced synaptic dysfunction
A Beta 诱导的突触功能障碍中钙调神经磷酸酶的激活和支架
- 批准号:
10527313 - 财政年份:2021
- 资助金额:
$ 40.84万 - 项目类别:
Creating a Chemical Probe to Identify the Target of a Novel Immune Suppressing Compound
创建化学探针来识别新型免疫抑制化合物的靶标
- 批准号:
9226933 - 财政年份:2016
- 资助金额:
$ 40.84万 - 项目类别:
Identifying Physiological and Molecular Inducers of Beta Cell Maturation
识别 β 细胞成熟的生理和分子诱导剂
- 批准号:
8717474 - 财政年份:2014
- 资助金额:
$ 40.84万 - 项目类别:
Identifying Physiological and Molecular Inducers of Beta Cell Maturation
识别 β 细胞成熟的生理和分子诱导剂
- 批准号:
9038361 - 财政年份:2014
- 资助金额:
$ 40.84万 - 项目类别:














{{item.name}}会员




